| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10731974 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 413 journal articles in the PubMed database | Email to a friend | | |
| Sikorska-Fic B, Makowska K, Rokicka-Milewska R
[New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase] [Journal Article]
Wiad Lek 1998.:233-6.
Abstract | Full Citation | Find Related Articles | | Vieira Pinheiro JP, Müller HJ, Schwabe D, et al.
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia. [Journal Article]
Br J Haematol 2001 Apr; 113(1):115-9.
Abstract | Full Citation | Find Related Articles | | Wang B, Relling MV, Storm MC, et al.
Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. [Journal Article]
Leukemia 2003 Aug; 17(8):1583-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Larson RA, Fretzin MH, Dodge RK, et al.
Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. [Journal Article]
Leukemia 1998 May; 12(5):660-5.
Abstract | Full Citation | Find Related Articles | | Ettinger LJ, Kurtzberg J, Voûte PA, et al.
An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study]
Cancer 1995 Mar 1; 75(5):1176-81.
Abstract | Full Citation | Find Related Articles | | Wenner KA, Vieira Pinheiro JP, Escherich G, et al.
Asparagine concentration in plasma after 2,500 IU/m(2) PEG-asparaginase i.v. in children with acute lymphoblastic leukemia. [Journal Article]
Klin Padiatr 2005 Nov-Dec; 217(6):321-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Woo MH, Hak LJ, Storm MC, et al.
Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. [Journal Article]
Leukemia 1998 Oct; 12(10):1527-33.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dinndorf PA, Gootenberg J, Cohen MH, et al.
FDA Drug Approval Summary: Pegaspargase (Oncaspar(R)) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL). [JOURNAL ARTICLE]
Oncologist 2007; 12(8):991-998.
Abstract | Full Citation | Find Related Articles | | Müller HJ, Löning L, Horn A, et al.
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. [Journal Article]
Br J Haematol 2000 Aug; 110(2):379-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
